Covered recipient · General Payments record
KRISTA MARIE KOZACKI
Allopathic & Osteopathic Physicians Family Medicine
General Payments · PY2018–2023
$3,759.58
- Reported across 279 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2023 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $411.13 | 27 |
By paying entity
PY2023 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $231.16 | 16 |
| SANOFI-AVENTIS U.S. LLC | $42.95 | 2 |
| Novo Nordisk AS | $33.48 | 2 |
| GlaxoSmithKline, LLC. | $28.54 | 2 |
| Sumitomo Pharma America, Inc. | $26.92 | 2 |
| DEXCOM, INC. | $18.60 | 1 |
| Amgen Inc. | $15.13 | 1 |
| Bayer HealthCare Pharmaceuticals Inc. | $14.35 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2023 (27)
Sorted by paying entity, then date · as published by CMS
Program year 2023 20182019202020212022
Record-level detail is published for PY2023; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $23.74 | 01/05/2023 | Food and Beverage | Undisputed | 01/23/2026 | 998165109 | CMS |
| ABBVIE INC. | $13.50 | 01/10/2023 | Food and Beverage | Undisputed | 01/23/2026 | 998165111 | CMS |
| ABBVIE INC. | $20.63 | 02/02/2023 | Food and Beverage | Undisputed | 01/23/2026 | 998165113 | CMS |
| ABBVIE INC. | $6.95 | 02/08/2023 | Food and Beverage | Undisputed | 01/23/2026 | 998165115 | CMS |
| ABBVIE INC. | $7.39 | 02/23/2023 | Food and Beverage | Undisputed | 01/23/2026 | 998165117 | CMS |
| ABBVIE INC. | $10.65 | 02/27/2023 | Food and Beverage | Undisputed | 01/23/2026 | 998165119 | CMS |
| ABBVIE INC. | $4.33 | 03/14/2023 | Food and Beverage | Undisputed | 01/23/2026 | 998165121 | CMS |
| ABBVIE INC. | $17.81 | 03/16/2023 | Food and Beverage | Undisputed | 01/23/2026 | 998165123 | CMS |
| ABBVIE INC. | $7.77 | 03/23/2023 | Food and Beverage | Undisputed | 01/23/2026 | 998165125 | CMS |
| ABBVIE INC. | $32.91 | 03/28/2023 | Food and Beverage | Undisputed | 01/23/2026 | 998165127 | CMS |
| ABBVIE INC. | $15.49 | 04/13/2023 | Food and Beverage | Undisputed | 01/23/2026 | 998165129 | CMS |
| ABBVIE INC. | $8.15 | 04/25/2023 | Food and Beverage | Undisputed | 01/23/2026 | 998165131 | CMS |
| ABBVIE INC. | $16.60 | 04/28/2023 | Food and Beverage | Undisputed | 01/23/2026 | 998165133 | CMS |
| ABBVIE INC. | $32.91 | 05/11/2023 | Food and Beverage | Undisputed | 01/23/2026 | 998165135 | CMS |
| ABBVIE INC. | $6.44 | 05/11/2023 | Food and Beverage | Undisputed | 01/23/2026 | 998165137 | CMS |
| ABBVIE INC. | $5.89 | 11/06/2023 | Food and Beverage | Undisputed | 01/23/2026 | 998165139 | CMS |
| Amgen Inc. | $15.13 | 03/08/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1020619235 | CMS |
| Bayer Healthcare Pharmaceuticals Inc. | $14.35 | 01/18/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1000069673 | CMS |
| Dexcom, Inc. | $18.60 | 01/10/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1054907255 | CMS |
| GlaxoSmithKline, LLC. | $14.01 | 05/09/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1003186293 | CMS |
| GlaxoSmithKline, LLC. | $14.53 | 06/16/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1003188647 | CMS |
| Novo Nordisk Inc | $12.95 | 01/31/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1000326539 | CMS |
| Novo Nordisk Inc | $20.53 | 02/14/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1000326545 | CMS |
| SANOFI-AVENTIS U.S. LLC | $19.95 | 03/02/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1049814283 | CMS |
| SANOFI-AVENTIS U.S. LLC | $23.00 | 04/18/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1049814323 | CMS |
| Sumitomo Pharma America, Inc. | $3.52 | 01/09/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1030876263 | CMS |
| Sumitomo Pharma America, Inc. | $23.40 | 04/04/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1030876259 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023
- Generated from
- OP_DTL_GNRL_PGYR2023_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.